Sharon Bio-Medicine: Board Meeting Intimation for Declaration Of Audited Financial Results For The Quarter And Year Ended March 31 2023

SHARON BIO-MEDICINE LTD.-has informed BSE that the meeting of the Board of Directors of the Company is scheduled on 30/05/2023 inter alia to consider and approve Pursuant to Regulation 29 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations 2015 the Audited Financial Results of the Company for the quarter and year ended March 31 2023 along with the Auditors Report thereon will be considered and approved on Tuesday May 30 2023 at the corporate office of the Company.